Kin Wah Terence Lee

Dr. Kin Wah Terence Lee

Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong 999077, China
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2007 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
SMStephanie KY Ma
Stephanie KY Ma
KCKwok–Wah Chan
Kwok–Wah Chan
LHLiang Hu
Liang Hu
KLKin Wah Terence Lee
Kin Wah Terence Lee
JWJana Yim–Hung Wo
Jana Yim–Hung Wo
Xin-Yuan GuanXin-Yuan Guan
Xin-Yuan Guan

24 September 2007 in Oncogene
Verified
Journal Article
Closed access
PDF file
SMS Ma
S Ma
KLKin Wah Terence Lee
Kin Wah Terence Lee
BZB-J Zheng
B-J Zheng
KCK W Chan
K W Chan
Xin-Yuan GuanXin-Yuan Guan
Xin-Yuan Guan

1 July 2011 in Cell Stem Cell
Verified
Journal Article
Closed access
KLKin Wah Terence Lee
Kin Wah Terence Lee
ACAntonia Castilho
Antonia Castilho
VCVincent Chi Ho Cheung
Vincent Chi Ho Cheung
KTKwan Ho Tang
Kwan Ho Tang
SMStephanie KY Ma
Stephanie KY Ma
INIrene Oi Lin Ng
Irene Oi Lin Ng

1 July 2008 in Molecular Cancer Research
Verified
Journal Article
Open access
PDF file
SMStephanie KY Ma
Stephanie KY Ma
KCKwok Wah Chan
Kwok Wah Chan
KLKin Wah Terence Lee
Kin Wah Terence Lee
KTKwan Ho Tang
Kwan Ho Tang
JWJana Yim-Hung Wo
Jana Yim-Hung Wo
Xin-Yuan GuanXin-Yuan Guan
Xin-Yuan Guan
Recent efforts in our study of cancer stem cells (CSC) in hepatocellular carcinoma (HCC) have led to the identification of CD133 as a prominent HCC CSC marker. Findings were based on experiments done on cell lines and xenograft tumors where expression of CD133 was detected at levels as high as 65%. Based on the CSC theory, CSCs are believed to represent only a minority number of the tumor mass. This is indicative that our previously characterized CD133+ HCC CSC population is still heterogeneous, consisting of perhaps subsets of cells with differing tumorigenic potential. We hypothesized that it is possible to further enrich the CSC population by means of additional differentially expressed markers. Using a two-dimensional PAGE approach, we compared protein profiles between CD133+ and CD133− subpopulations isolated from Huh7 and PLC8024 and identified aldehyde dehydrogenase 1A1 as one of the proteins that are preferentially expressed in the CD133+ subfraction. Analysis of the expression of several different ALDH isoforms and ALDH enzymatic activity in liver cell lines found ALDH to be positively correlated with CD133 expression. Dual-color flow cytometry analysis found the majority of ALDH+ to be CD133+, yet not all CD133+ HCC cells were ALDH+. Subsequent studies on purified subpopulations found CD133+ALDH+ cells to be significantly more tumorigenic than their CD133−ALDH+ or CD133−ALDH− counterparts, both in vitro and in vivo. These data, combined with those from our previous work, reveal the existence of a hierarchical organization in HCC bearing tumorigenic potential in the order of CD133+ALDH+ > CD133+ALDH− > CD133−ALDH−. ALDH, expressed along CD133, can more specifically characterize the tumorigenic liver CSC population. (Mol Cancer Res 2008;6(7):1146–53)

15 September 2006 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
KLKin Wah Terence Lee
Kin Wah Terence Lee
RPRonnie T.P. Poon
Ronnie T.P. Poon
AYAnthony P. Yuen
Anthony P. Yuen
MLMing Tat Ling
Ming Tat Ling
WKWei Kei Kwok
Wei Kei Kwok
SFSheung Tat Fan
Sheung Tat Fan
Purpose: Hepatocellular carcinoma (HCC) is a rapidly growing tumor associated with a high propensity for vascular invasion and metastasis. Epithelial-mesenchymal transition (EMT) is a key event in the tumor invasion process. Recently, Twist has been identified to play an important role in EMT-mediated metastasis through the regulation of E-cadherin expression. However, the actual role of Twist in tumor invasiveness remains unclear. The purpose of this study is to investigate the expression and possible role of Twist in HCC. Experimental Design: We evaluated Twist and E-cadherin expression in HCC tissue microarray of paired primary and metastatic HCC by immunohistochemical staining. The role of Twist in EMT-mediated invasiveness was also evaluated in vitro in HCC cell lines. Results: We first showed that overexpression of Twist was correlated with HCC metastasis (P = 0.001) and its expression was negatively correlated with E-cadherin expression (P = 0.001, r = −0.443) by tissue microarray. A significant increase of Twist at the mRNA level was also found in metastatic HCC cell lines MHCC-97H, MHCC-97L, and H2M when compared with nonmetastatic Huh-7, H2P, and PLC cell lines. The MHCC-97H cell line, which has a higher metastatic ability, was found to have a higher level of Twist than MHCC-97L. Accompanied with increased Twist expression in the metastatic HCC cell lines when compared with the nonmetastatic primary ones, we found decreased E-cadherin mRNA expression in the metastatic HCC cell lines. By ectopic transfection of Twist into PLC cells, Twist was able to suppress E-cadherin expression and induce EMT changes, which was correlated with increased HCC cell invasiveness. Conclusion: This study shows that Twist overexpression was correlated with HCC metastasis through induction of EMT changes and HCC cell invasiveness.

1 December 2010 in Cell Stem Cell
Verified
Journal Article
Closed access
SMStephanie KY Ma
Stephanie KY Ma
KTKwan Ho Tang
Kwan Ho Tang
YCYuen Piu Chan
Yuen Piu Chan
KLKin Wah Terence Lee
Kin Wah Terence Lee
PKPak Shing Kwan
Pak Shing Kwan
Xin-Yuan GuanXin-Yuan Guan
Xin-Yuan Guan